Lista de obras - Janusz Menkiszak - Dominio Público Uruguay

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases

scientific article published on 25 June 2019

A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy

scientific article published on 26 September 2019

A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer

artículo científico publicado en 2003

A high proportion of founder BRCA1 mutations in Polish breast cancer families

artículo científico publicado en 2004

A personalised approach to prostate cancer screening based on genotyping of risk founder alleles

artículo científico publicado en 2013

A protein truncating BRCA1 allele with a low penetrance of breast cancer

artículo científico publicado en 2004

A rare case of peritoneal disseminated angiosarcoma 20 years after ovarian cancer diagnosis

artículo científico publicado en 2013

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

artículo científico

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

artículo científico publicado en 2018

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

artículo científico publicado en 2013

Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions.

artículo científico publicado en 2015

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

artículo científico publicado en 2012

Association of common WRAP 53 variant with ovarian cancer risk in the Polish population

artículo científico publicado en 2012

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor

artículo científico publicado en 2022

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

Attitudes toward preventive oophorectomy among BRCA1 mutation carriers in Poland

artículo científico publicado en 2004

BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms

artículo científico publicado en 2009

Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?

artículo científico publicado en 2016

Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status

artículo científico publicado en 2005

Characteristics of selected clinical features in BRCA1 mutation carriers affected with breast cancer undergoing preventive female genital tract surgeries

artículo científico publicado en 2013

Characteristics of selected features of hereditary ovarian cancer in carriers of constitutional BRCA1 gene mutation

scientific article published on 01 November 2002

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

artículo científico publicado en 2018

Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer

artículo científico publicado en 2017

Clinical characteristics of hereditary ovarian cancer (HOC) in Poland

scientific article published on 01 September 2002

Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer

artículo científico publicado en 2018

Clinical genetic services for familial breast cancer in Poland

artículo científico publicado en 1999

Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients

artículo científico publicado en 2017

Conservative treatment of a young patient with thyroid carcinoma in adult ovarian teratoma - case report.

artículo científico publicado en 2014

Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?

artículo científico publicado en 2018

Detection of germline mutations in the BRCA1 gene by RNA-based sequencing

artículo científico publicado en 2001

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

scientific article published on 17 June 2020

Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.

artículo científico publicado en 2016

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

artículo científico publicado en 2017

Ectopic pregnancy treatment by combination therapy

artículo científico publicado en 2016

Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer.

artículo científico publicado en 2018

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer

artículo científico publicado en 2000

HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases

artículo científico publicado en 2017

HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases

artículo científico publicado en 2014

Hereditary breast and ovarian cancer

artículo científico publicado en 2008

Hereditary ovarian cancer in Poland.

artículo científico publicado en 2003

Implementation of an enhanced recovery after surgery (ERAS) protocol in a gynaecology department - the follow-up at 1 year

artículo científico publicado en 2017

Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk

artículo científico publicado en 2007

Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer

artículo científico publicado en 2016

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome

artículo científico publicado en 2014

MMP3 in Comparison to CA 125, HE4 and the ROMA Algorithm in Differentiation of Ovarian Tumors

artículo científico publicado en 2016

Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks

scientific article published on 25 October 2006

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

artículo científico publicado en 2013

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

artículo científico publicado en 2018

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

artículo científico publicado en 2015

Non-random transmission of mutant alleles to female offspring of BRCA1 carriers in Poland

artículo científico publicado en 2003

Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism

artículo científico publicado en 2008

Ovarian cystadenoma as a characteristic feature of families with hereditary ovarian cancers unassociated with BRCA1 and BRCA2 mutations.

artículo científico publicado en 2004

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

artículo científico publicado en 2016

Parovarian cysts--not always benign

artículo científico publicado el 1 de noviembre de 2002

Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.

artículo científico publicado en 2016

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

artículo científico publicado en 2021

Risk Model in Women with Ovarian Cancer Without Mutations

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10

artículo científico publicado en 2013

Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy

Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.

artículo científico publicado en 2014

Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer.

artículo científico publicado en 2018

The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer

artículo científico publicado en 2012

The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers

artículo científico publicado en 2007

The VEGF_936_C>T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women

artículo científico publicado en 2008

The impact of an expanded genetic testing program and selective oophorectomy on the incidence of ovarian cancer in West Pomerania

artículo científico publicado en 2016

The presence of prostate cancer at biopsy is predicted by a number of genetic variants

artículo científico publicado en 2013

The role of lipocalin-2 serum levels in the diagnostics of endometrial cancer

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

artículo científico publicado en 2017

Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer

artículo científico publicado en 2014

Lista de obras de Janusz Menkiszak

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases

A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy

A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer

A high proportion of founder BRCA1 mutations in Polish breast cancer families

A personalised approach to prostate cancer screening based on genotyping of risk founder alleles

A protein truncating BRCA1 allele with a low penetrance of breast cancer

A rare case of peritoneal disseminated angiosarcoma 20 years after ovarian cancer diagnosis

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions.

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

Association of common WRAP 53 variant with ovarian cancer risk in the Polish population

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

Attitudes toward preventive oophorectomy among BRCA1 mutation carriers in Poland

BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms

Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?

Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status

Characteristics of selected clinical features in BRCA1 mutation carriers affected with breast cancer undergoing preventive female genital tract surgeries

Characteristics of selected features of hereditary ovarian cancer in carriers of constitutional BRCA1 gene mutation

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer

Clinical characteristics of hereditary ovarian cancer (HOC) in Poland

Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer

Clinical genetic services for familial breast cancer in Poland

Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients

Conservative treatment of a young patient with thyroid carcinoma in adult ovarian teratoma - case report.

Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?

Detection of germline mutations in the BRCA1 gene by RNA-based sequencing

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Ectopic pregnancy treatment by combination therapy

Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer.

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer

HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases

HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases

Hereditary breast and ovarian cancer

Hereditary ovarian cancer in Poland.

Implementation of an enhanced recovery after surgery (ERAS) protocol in a gynaecology department - the follow-up at 1 year

Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk

Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome

MMP3 in Comparison to CA 125, HE4 and the ROMA Algorithm in Differentiation of Ovarian Tumors

Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Non-random transmission of mutant alleles to female offspring of BRCA1 carriers in Poland

Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism

Ovarian cystadenoma as a characteristic feature of families with hereditary ovarian cancers unassociated with BRCA1 and BRCA2 mutations.

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

Parovarian cysts--not always benign

Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

Risk Model in Women with Ovarian Cancer Without Mutations

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10

Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy

Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.

Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer.

The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer

The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers

The VEGF_936_C>T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women

The impact of an expanded genetic testing program and selective oophorectomy on the incidence of ovarian cancer in West Pomerania

The presence of prostate cancer at biopsy is predicted by a number of genetic variants

The role of lipocalin-2 serum levels in the diagnostics of endometrial cancer

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer